Adults 15 to 19, female only, with Contraception or Contraceptive Usage. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of IN Control Pilot Program (Feeling Comfortable, Listened to, Helpful, Easy to Contact) Feeling SatisfiedPrimary· Within 2-4weeks after contact with the IN-Control Program
Survey of participants that interacted with navigator program (number of participants reporting that the navigator program was easy to contact, made them feel comfortable, listened to and helpful)
Group
Value
95% CI
Pilot Study Participants
17
Sponsor's own description
The goal of this study is to pilot test the IN-Control Birth Control Navigator Program in Central Indiana for use by adolescents who would like to access birth control. The investigators hypothesize that facilitating access to contraception through our intervention will ultimately result in increased feelings of autonomy around these decisions and use of hormonal contraception.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
NCT07365904 — Investigating Ovulation Inhibition for Use as a Contraceptive
· Phase 2
· recruiting
NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period
· active not recruiting
NCT06823037 — Hormonal Contraception Access Through Pharmacist Prescribing Implementation
· NA
· recruiting
NCT07326007 — Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women W
· NA
· recruiting
NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
· NA
· recruiting
Other Indiana University trials
Trials by the same sponsor.
NCT07470086 — The Role of Environmental Temperatures in Respiratory Control
· NA
· not yet recruiting
NCT07470099 — The Role of Breathing Perception in Respiratory Control
· NA
· not yet recruiting
NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
· Phase 2
· not yet recruiting
NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers
· not yet recruiting
NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
· Phase 1, PHASE2
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Indiana University
Last refreshed: 19 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05691270.